SCHEMBL15564432

SCHEMBL15564432

C1CCC(NC2CCCCC2)CC1.C[C@H](O)[C@H](NC(=O)OC(C)(C)C)C(=O)O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.44
EPHX1 P07099 2/20 0.43
HDAC4 P56524 1/20 0.43
HDAC1 Q13547 1/20 0.43
HDAC6 Q9UBN7 1/20 0.43
CTSK P43235 5/20 0.42
CTSS P25774 4/20 0.42
BTK Q06187 1/20 0.42
ALDH1A1 P00352 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
KMT2A Q03164 1/20 0.38
TSHR P16473 2/20 0.38
KDM1A O60341 1/20 0.38
MAOB P27338 1/20 0.38
CTSL P07711 1/20 0.38
CTSB P07858 1/20 0.38
APP P05067 1/20 0.38
CA1 P00915 1/20 0.36
CA2 P00918 1/20 0.36
CA7 P43166 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10678116 1.00 GAA (0.44) GAAEPHX1HDAC4HDAC1HDAC6
SCHEMBL10678127 1.00 GAA (0.44) GAAEPHX1HDAC4HDAC1HDAC6
SCHEMBL29400759 0.86 CTSS (0.52) GAAEPHX1HDAC4HDAC1HDAC6
SCHEMBL3311034 0.85 GAA (0.43) GAAEPHX1HDAC4HDAC1HDAC6
SCHEMBL999110 0.84 CTSK (0.51) GAACTSKCTSSKMT2ATSHR
SCHEMBL16710007 0.84 CTSK (0.51) GAACTSKCTSSKMT2ATSHR
SCHEMBL1312765 0.84 CTSK (0.51) GAACTSKCTSSKMT2ATSHR
SCHEMBL708582 0.84 CTSK (0.51) GAACTSKCTSSKMT2ATSHR
SCHEMBL1312767 0.84 CTSK (0.51) GAACTSKCTSSKMT2ATSHR
SCHEMBL1311851 0.84 CTSK (0.51) GAACTSKCTSSKMT2ATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9394263-B2 Substituted hetero-azepinones F. HOFFMANN-LA ROCHE AG (CH) 2016-07-19 US disclosed
US-20150361059-A1 SUBSTITUTED HETERO-AZEPINONES HOFFMAN-LA ROCHE INC. (US) 2015-12-17 US disclosed
EP-2882725-A1 SUBSTITUTED HETERO-AZEPINONES F. Hoffmann-La Roche AG (CH) 2015-06-17 EP disclosed
WO-2014023708-A1 SUBSTITUTED HETERO-AZEPINONES F. HOFFMANN-LA ROCHE AG (CH) 2014-02-13 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150361059-A1 SUBSTITUTED HETERO-AZEPINONES CCNY, CCNE1, CCND3 GAA 2880/4885EPHX1 1550/4885HDAC4 2442/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.